Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Effect of Growth Hormone Replacement on Liver Fat

This study has been completed.
Sponsor:
Collaborator:
Novo Nordisk A/S
Information provided by:
Imperial College London
ClinicalTrials.gov Identifier:
NCT00774579
First received: October 16, 2008
Last updated: December 18, 2009
Last verified: December 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2009
  Primary Completion Date: March 2009 (Final data collection date for primary outcome measure)